Q/C Technologies, Inc. (QCLS)
Nasdaq: QCLS · In Vitro & In Vivo Diagnostic Substances · New York, NY · filing with the SEC since 2005
The company now
Q/C Technologies, Inc. is classed by the SEC under In Vitro & In Vivo Diagnostic Substances (industry code 2835), based in New York, NY. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported a loss of $12 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.